Old drug tested for new hope in slowing kidney decline
NCT ID NCT07315139
Summary
This study tested whether pentoxifylline, an existing medication, could reduce inflammation and slow the progression of chronic kidney disease in patients without diabetes. It involved 42 adults with moderate to advanced kidney disease. Researchers measured levels of inflammatory markers to see if the drug had a beneficial effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ain Shams University
Cairo, 11591, Egypt
Conditions
Explore the condition pages connected to this study.